Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 501–600 of 938
Advances in paraganglioma–pheochromocytoma cell lines and xenografts
Bayley, J., & Devilee, P. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0434 · Cited by 26
“It is worth noting that most clinical PPGL cases are caused by variants in metabolismrelated genes, which currently include SDHA, SDHB, SDHC, SDHD, SDHAF2, FH, MDH2, IDH1, IDH2, DLST, GOT2 and SLC25A11.”
BackgroundExon Junction Complex Mediates the Cap-Independent Translation of Circular RNA
Lin, H.-H., Chang, C.-Y., Huang, Y.-R., Shen, C., Wu, Y.-C., Chang, K.-L., Lee, Y., Lin, Y., Ting, W., Chien, H., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0877 · Cited by 26
Research progress on the pathogenesis of the SDHB mutation and related diseases
Liu, C., Zhou, D., Yang, K., Xu, N., Peng, J., & Zhu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115500 · Cited by 26
Impacts of isopyrazam exposure on the development of early-life zebrafish (Danio rerio)
Yao, H., Xu, X. L., Zhou, Y., & Xu, C. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-2449-5 · Cited by 26
Skonieczna, K., Malyarchuk, B. А., & Grzybowski, T. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.004 · Cited by 26
Complex II inactivation is lethal in the nematode Caenorhabditis elegans
Ichimiya, H., Huet, R. G., Hartman, P. S., Amino, H., Kita, K., & Ishii, N. (2002) · Mitochondrion · doi:10.1016/s1567-7249(02)00069-7 · Cited by 26
The Role of Nuclear-Encoded Mitochondrial tRNA Charging Enzymes in Human Inherited Disease
Greco, C. D., & Antonellis, A. (2022) · Genes · doi:10.3390/genes13122319 · Cited by 26
“such as paragangliomas associated with mutations in SDHC (succinate dehydrogenase complex subunit C) [13,16].”
BackgroundLago, C. U., Nowinski, S. M., Rundhaug, J. E., Pfeiffer, M. E., Kiguchi, K., Hirasaka, K., Yang, X., Abramson, E. M., Bratton, S. B., Rho, O., et al. (2012) · Oncogene · doi:10.1038/onc.2011.630 · Cited by 25
Current Understanding of Mitochondrial DNA in Breast Cancer
Radpour, R., Fan, A. X., Kohler, C., Holzgreve, W., & Zhong, X. Y. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00767.x · Cited by 25
New Advances in the Genetics of Pheochromocytoma and Paraganglioma Syndromes
Gimenez‐Roqueplo, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.012 · Cited by 25
von Arx, C., Capozzi, M., López-Jiménez, E., Ottaiano, A., Tatangelo, F., Di Mauro, A., Nasti, G., Tornesello, M. L., & Tafuto, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091277 · Cited by 24
SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma
Bayley, J., Bausch, B., Jansen, J. C., Hensen, E. F., van der Tuin, K., Corssmit, E. P. M., Devilee, P., & Neumann, H. P. H. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107656 · Cited by 24
Moro, T., Nakao, S., Sumiyoshi, H., Ishii, T., Miyazawa, M., Ishii, N., Sato, T., Iida, Y., Okada, Y., Tanaka, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146592 · Cited by 24
“From this point of view, it is interesting that germline SDHCmutations have been reported in several patients [33, 34].”
BackgroundMitochondrial metabolic remodeling in response to genetic and environmental perturbations
Hollinshead, K. E. R., & Tennant, D. A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1334 · Cited by 24
Maher, M. J., Herath, A. S., Udagedara, S. R., Dougan, D. A., & Truscott, K. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800195115 · Cited by 24
The role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 24
A high-throughput screen for single gene activities: isolation of apoptosis inducers
Albayrak, T., & Grimm, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00653-3 · Cited by 24
Müller, U. (2011) · Neurogenetics · doi:10.1007/s10048-011-0280-y · Cited by 24
“Mutations in SDHC [19] are rare and make up only about 4% of hereditary PGL/PCC cases.”
BackgroundSelf-citationGlutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
Sarkadi, B., Meszaros, K., Krencz, I., Canu, L., Krokker, L., Zakarias, S., Barna, G., Sebestyen, A., Papay, J., Hujber, Z., et al. (2020) · Cancers · doi:10.3390/cancers12030599 · Cited by 23
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 23
“Soon after the identification of SDHD, mutations in SDHC and SDHB genes were found to be responsible for PGL3 and PGL4, respectively (18, 19).”
BackgroundSDHC phaeochromocytoma and paraganglioma: A UK‐wide case series
Williams, S. T., Chatzikyriakou, P., Carroll, P., McGowan, B. M., Velusamy, A., White, G., Obholzer, R., Akker, S. A., Tufton, N., Casey, R. T., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14594 · Cited by 23
“While SDHC cases have been described as developing benign HNPGLs, six cases developed malignant HNPGLs (20%), >50mm at diagnosis.(13,25) Two metastatic EAPGL cases presented young (12 and 30 years), with tumours >45mm.”
BackgroundPaepe, B. D. (2012) · ISRN Pathology · doi:10.5402/2012/217162 · Cited by 23
“Hereditary paraganglioma has been linked to SDHA [88], SDHB [89], SDHC [90], and SDHD [91] gene mutations.”
BackgroundNew genetic causes of pheochromocytoma: current concepts and the clinical relevance
Neumann, H. P. H., Cybulla, M., Shibata, H., Oya, M., Naruse, M., Higashihara, E., Terachi, T., Ling, H., Takami, H. E., Shuin, T., et al. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.15 · Cited by 23
Marzola, M. C., Chondrogiannis, S., Grassetto, G., Rampin, L., Maffione, A. M., Ferretti, A., Opocher, G., Schiavi, F., Colletti, P. M., & Rubello, D. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31829aface · Cited by 23
Raygada, M. J., King, K. S., Adams, K. T., Stratakis, C. A., & Pacák, K. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0369 · Cited by 23
Pheochromocytomas and Paragangliomas—Current Management
Brewczyński, A., Kolasińska, A. D., Jabłońska, B., & Wyrwicz, L. S. (2025) · Cancers · doi:10.3390/cancers17061029 · Cited by 22
“Abnormal laboratory results (increased metanephrine and catecholamine secretion) or neck tumors are common indications for radiological diagnostics [11,21,63,65–68].”
Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies
Renella, R., Carnevale, J. C., Schneider, K. A., Hornick, J. L., Rana, H. Q., & Janeway, K. A. (2014) · Familial Cancer · doi:10.1007/s10689-014-9725-4 · Cited by 23
Hoekstra, A. S., Addie, R. D., Ras, C., Seifar, R. M., Ruivenkamp, C. A. L., Bruijn, I. H. B., Hes, F. J., Jansen, J. C., Corssmit, E. P. M., Corver, W. E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw218 · Cited by 22
“SDHD and SDHAF2 are both located on the long arm of chromosome 11, whereas the SDHA, SDHB and SDHC subunit genes are located on chromosome 5 (SDHA) or chromosome 1 (SDHB and SDHC).”
BackgroundPheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein, L. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1184-y · Cited by 22
Amin, M. A., & Ameen, N. F. E. (2012) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-012-2084-6 · Cited by 22
“and others who reported that 10 % of paragangliomas are multicentric in origin [2, 5, 13, 14].”
BackgroundCellular Respiration and Carcinogenesis
Sarangarajan, R., & Apte, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3 · Cited by 23
Liu, X., Hong, R., Du, P., Yang, D., He, M., Wu, Q., Li, L., Wang, Y., Chen, J., Min, Q., et al. (2022) · Theranostics · doi:10.7150/thno.70814 · Cited by 21
“The mutations in the genes of isocitrate dehydrogenase (IDH1/IDH2) [8-13] and succinate dehydrogenase (SDHA/SDHB/SDHC/SDHD) [14-21] families, and fumarate hydratase (FH) [22] were found in many types of human cancers.”
BackgroundSmestad, J. A., Hamidi, O., Wang, L., Holte, M. N., Khazal, F. J. A., Erber, L. N., Chen, Y., & Maher, L. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23639 · Cited by 21
Mouse Models of Human Familial Paraganglioma
Maher, L. J., III, Emily, H., Emily, M., Nicole, A., Paul, J., Nelson-Holte, M. H., Piruat, J. I., García‐Flores, P., López‐Barneo, J., & van, J. (2011) · InTech eBooks · doi:10.5772/25346 · Cited by 21
Pediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutations
Mora, J., Cascón, A., Robledo, M., & Català, A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20680 · Cited by 21
Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209788488517 · Cited by 21
“Germline mutations caused autosomal dominant paraganglioma type 3 (PGL-3), a form without genetic imprinting [43].”
BackgroundHigh prevalence of SDHB mutations in head and neck paraganglioma in Belgium
Persu, A., Hamoir, M., Grégoire, V., Garin, P., Duvivier, E., Reychler, H., Chantrain, G., Mortier, G. R., Mourad, M., Maiter, D. M., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ffdc54 · Cited by 21
Campione, E., Terrinoni, A., Orlandi, A., Codispoti, A., Melino, G., Bianchi, L., Mazzotta, A., Garaci, F. G., Ludovici, A., & Chimenti, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700851 · Cited by 21
Kummer, W., & Yamamoto, Y. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10197 · Cited by 21
“A mutation in SDH-D has been found in familial glomus tumors classified as paraganglioma type 1 (Baysal et al., 2000) and a point mutation in the start codon of SDH-C and loss of heterozygosity in the tumor was associated with familial glomus tumor, paraganglioma type 3 (Niemann and Müller, 2000).”
BackgroundInfluentialRicketts, C. J., Killian, J. K., Vocke, C. D., Wang, Y., Merino, M. J., Meltzer, P. S., & Linehan, W. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278108 · Cited by 20
SDHA related phaeochromocytoma and paraganglioma: review and clinical management
Kaplan, A. I., Dwight, T., Luxford, C., Benn, D. E., & Clifton-Bligh, R. J. (2024) · Endocrine Related Cancer · doi:10.1530/erc-24-0111 · Cited by 20
“The causal link between germline PVs in SDHB, SDHC, and SDHD and development of PPGL is well established (Baysal et al. 2000, Niemann & Muller 2000), with SDHB PVs associated with a higher risk of metastasis (Astuti et al. 2001).”
BackgroundCasting an eye on the Krebs cycle
Münnich, A. (2008) · Nature Genetics · doi:10.1038/ng1008-1148 · Cited by 20
SDHB mutation analysis in familial and sporadic phaeochromocytoma identifies a novel mutation
Cascón, A., Cebrián, A., Ruiz-Llorente, S., Tellería, D., Benítez, J., & Robledo, M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.e64 · Cited by 20
TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation
Niture, S. K., Lin, M., Odera, J. O., Moore, J. T., Zhe, H., Chen, X. L., Suy, S., Collins, S. P., & Kumar, D. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105885 · Cited by 19
Hayashi, J., Hashizume, O., Ishikawa, K., & Shimizu, A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.004 · Cited by 19
Papaspyrou, K., Rossmann, H., Fottner, C., Weber, M. M., Mann, W. J., Lackner, K. J., & Helling, K. (2008) · Head & Neck · doi:10.1002/hed.20746 · Cited by 19
Bayley, J., Weiss, M. M., Grimbergen, A., van Brussel, B. T. J., Hes, F. J., Jansen, J. C., Verhoef, S., Devilee, P., Corssmit, E. P. M., & Vriends, A. H. J. T. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0084 · Cited by 19
“Further subunits of SDH were subsequently shown to be involved in both head and neck paragangliomas and pheochromocytoma (Niemann & Muller 2000, Astuti et al .”
BackgroundZhao, Z., Rothery, R. A., & Weiner, J. H. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-188 · Cited by 18
“2000), whereas mutations in the sdhB, sdhC, or sdhD gene can result in paraganglioma (PGL) or pheochromocytoma tumors (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundVenkatesan, A. M., Trivedi, H., Adams, K. T., Kebebew, E., Pacák, K., & Hughes, M. S. (2011) · Surgery · doi:10.1016/j.surg.2011.09.026 · Cited by 19
Zeviani, M., & Klopstock, T. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200110000-00002 · Cited by 19
Novel Hereditary Forms of Pheochromocytomas and Paragangliomas
Dahia, P. L. M. (2013) · Frontiers of hormone research · doi:10.1159/000345671 · Cited by 18
Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome
Patócs, A., Lendvai, N. K., Butz, H., Likó, I., Sápi, Z., Szücs, N., Tóth, G., Grolmusz, V. K., Igaz, P., Tóth, M., et al. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0050-0 · Cited by 18
Functional Consequences of Succinate Dehydrogenase Mutations
Opocher, G., & Schiavi, F. (2011) · Endocrine Practice · doi:10.4158/ep11070.ra · Cited by 18
Huang, K. T., Dobrovic, A., & Fox, S. B. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-194 · Cited by 18
Bausch, B., Boedeker, C. C., Berlis, A., Brink, I., Cybulla, M., Walz, M. K., Januszewicz, A., Letizia, C., Opocher, G., Eng, C., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.013 · Cited by 18
From Transcriptional Profiling to Tumor Biology in Pheochromocytoma and Paraganglioma
Cascón, A., & Tennant, D. A. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9195-x · Cited by 17
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
Brinkley, G. J., Nam, H., Shim, E., Kirkman, R. L., Kundu, A., Karki, S., Heidarian, Y., Tennessen, J. M., Liu, J., Locasale, J. W., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045898 · Cited by 17
“To date, these molecules include the tricarboxylic acid (TCA) cycle intermediates succinate and fumarate as well as both enantiomers of 2-hydroxyglutarate (D-2HG and L-2HG) (Tomlinson et al., 2002; Baysal et al., 2000; Niemann and Müller, 2000; Parsons et al., 2008; Yan et al., 2009; Green and Beer, 2010; Mardis et al…”
BackgroundMontani, M., Schmitt, A. M., Schmid, S., Locher, T., Saremaslani, P., Heitz, P. U., Komminoth, P., & Perren, A. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00996 · Cited by 17
“Mutations of the tumor suppressor genes SDHD (Baysal et al. 2000), SDHC (Niemann & Muller 2000) and SDHB (Astuti et al. 2001) have recently been described in familial paragangliomas and pheochromocytomas.”
BackgroundInfluentialElse, T. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0221 · Cited by 17
Metabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma
Dwight, T., Kim, E., Novos, T., & Clifton-Bligh, R. J. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0926-3790 · Cited by 16
Hensen, E. F., Goeman, J. J., Oosting, J., van der Meij, A. G. L., Hogendoorn, P. C. W., Cremers, C. W. R. J., Devilee, P., & Cornelisse, C. J. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-25 · Cited by 17
“The latter were defined as 'sporadic' because mutation scanning of SDHB, SDHC, and SDHD was negative, while the family histories of these cases were negative for HN-paraganglioma or any of the other clinical stigmata that would suggest the involvement of VHL, NF1 or the RET gene.”
InfluentialAn Examination of Chimpanzee Use in Human Cancer Research
Bailey, J. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700410 · Cited by 17
Novel mutation in the TMEM 127 gene associated with phaeochromocytoma
Elston, M. S., Meyer-Rochow, G. Y., Prosser, D. O., Love, D. R., & Conaglen, J. V. (2013) · Internal Medicine Journal · doi:10.1111/imj.12088 · Cited by 16
Crona, J., Ljungström, V., Welin, S., Walz, M. K., Hellman, P., & Björklund, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133210 · Cited by 16
“A total of eighteen genes have been described as disease causing and these loci constitute 25 kilo base pairs spanning through 196 different exons [2–15].”
BackgroundModel systems in SDHx-related pheochromocytoma/paraganglioma
Takács‐Vellai, K., Farkas, Z., Ősz, F., & Stewart, G. W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10009-z · Cited by 16
Update on the Molecular Diagnosis of Endocrine Tumors: Toward –omics-Based Personalized Healthcare?
Weber, F., & Eng, C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0212 · Cited by 16
Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues
He, X., & Cao, X. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.57 · Cited by 16
Ishii, T., Yasuda, K., Miyazawa, M., Mitsushita, J., Johnson, T. E., Hartman, P. S., & Ishii, N. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.02.013 · Cited by 16
Bennedbæk, M., Rossing, M., Rasmussen, Å. K., Gerdes, A., Skytte, A., Jensen, U. B., Nielsen, F. C., & Hansen, T. V. O. (2016) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-016-0053-6 · Cited by 16
“protein 127 (TMEM127), MYC-associated factor X (MAX), fumarate hydratase (FH), and succinate dehydrogenase complex subunit A, B, C, D, and AF2 (SDHA, SDHB, SDHC, SDHD, SDHAF2) [3–13].”
Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes
Sharma, S., Wang, J., Gomez, E. C., Taggart, R. T., & Baysal, B. E. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx041 · Cited by 16
Zhu, W. D., Wang, Z. Y., Chai, Y., Wang, X. W., Chen, D. Y., & Wu, H. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.05.008 · Cited by 16
Rare diseases in clinical endocrinology: a taxonomic classification system
Marcucci, G., Cianferotti, L., Beck-Peccoz, P., Capezzone, M., Cetani, F., Colao, A., Davì, M. V., Uberti, E. C. D., Prato, S. D., Elisei, R., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0202-6 · Cited by 16
Velasco, A., Palomar-Asenjo, V., Ga??an, L., Catasús, L., Llecha, N., Panizo, Á., Palomar-Garcia, V., Quer, M., & Matías‐Guiu, X. (2005) · Diagnostic Molecular Pathology · doi:10.1097/01.pas.0000158987.07907.7e · Cited by 16
“SDHD, SDHB, and SHDC map to chromosome 11q23, 1p35-36, and 1q21-23, respectively.(3,18) They are composed of four, eight, and six exons, respectively.”
BackgroundPapa, S., Petruzzella, V., & Scacco, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_5 · Cited by 16
Eng, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn263 · Cited by 16
Stölting, G., Vo, K. N. T., Haus, J., & Scholl, U. I. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01020-6 · Cited by 17
Arenillas, C., Celada, L., Ruiz-Cantador, J., Calsina, B., Datta, D., García‐Galea, E., Fasani, R., Moreno-Cárdenas, A. B., Alba‐Linares, J. J., Miranda, B., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0943 · Cited by 15
“Heterozy-gous SDHC mutations predispose humans to PPGL (121).”
Rubinstein, W. S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.008 · Cited by 15
A rare case of Cushing syndrome by cyclic ectopic-ACTH
Farage, M., Costa, M. A. D. D. L., & Godoy‐Matos, A. F. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000500008 · Cited by 15
“Heterozygous mutations of the last three subunits have been associated with a genetic predisposition to HNPGLs and adrenal/extra-adrenal pheochromocytomas (PHEOs) (15,16).”
BackgroundMitochondrial substrates in cancer: Drivers or passengers?
Kruspig, B., Zhivotovsky, B., & Gogvadze, V. G. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.08.007 · Cited by 15
Paragangliomas Arising in the Head and Neck
Williams, M. D., & Rich, T. A. (2014) · Surgical pathology clinics · doi:10.1016/j.path.2014.08.007 · Cited by 15
Sir Hans Adolf Krebs: Architect of Metabolic Cycles
Wilson, B. A., Schisler, J. C., & Willis, M. S. (2010) · Laboratory Medicine · doi:10.1309/lmz5zlac85gfmghu · Cited by 15
ROS control in human iPS cells reveals early events in spontaneous carcinogenesis
Oka, S., Hayashi, M., Taguchi, K., Hidaka, M., Tsuzuki, T., & Sekiguchi, M. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz081 · Cited by 15
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma
Mannelli, M., Rapizzi, E., Fucci, R., Canu, L., Ercolino, T., Luconi, M., & Young, W. F. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0215 · Cited by 15
Pheochromocytoma: When to search a germline defect?
Buffet, A., Burnichon, N., Amar, L., & Gimenez‐Roqueplo, A. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.003 · Cited by 14
Surveillance of succinate dehydrogenase gene mutation carriers: Insights from a nationwide cohort
Martins, R. G., Cunha, N., Simões, H., Matos, M. J., Silva, J., Torres, I., Rodrigues, F., Leite, V. A. P. H., Teixeira, M. R., & Bugalho, M. J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14184 · Cited by 14
Genetics of pheochromocytoma and paraganglioma: New developments
Pigny, P., & Cardot-Bauters, C. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.11.004 · Cited by 14
“For two of them, the susceptibility gene was dentified shortly thereafter: SDHD for PGL1 (mapped to 11q23 egion) in 2000 [6] and SDHC for PGL3 (1q23) in 2000 [7].”
BackgroundGenetics of Pheochromocytoma and Paraganglioma
Pereira, B. D., Luíz, H. V., Ferreira, A. G., & Portugal, J. (2019) · Codon Publications eBooks · doi:10.15586/paraganglioma.2019.ch1 · Cited by 13
“PGL3 (MIM #506373) is caused by mutations in SDHC gene (84).”
BackgroundTherapies targeting the signal pathways of pheochromocytoma and paraganglioma
Liu, Y., Liu, L., & Zhu, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s219056 · Cited by 14
“SDHB mutations and SDHC mutations were also proven to have relationship with PCC/PGL.(50,51) In 2000, SDHD mutations were found in sporadic and hereditary PGL/PCC.”
BackgroundCharacteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma
Kim, J. H., Kim, M. J., Kong, S. H., Kim, S. J., Kang, H., Shin, C. S., Park, S. S., Lee, K. E., & Seong, M. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107102 · Cited by 14
Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms
Bellizzi, A. M. (2013) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2013.11.001 · Cited by 14
Poeppel, T. D., Yuece, A., Boy, C., Metz, K. A., Kaminsky, E., Neumann, H. P. H., Rosenbaum, S. J., Mann, K., & Moeller, L. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2269 · Cited by 14
68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas
Şimşek, D. H., Şanlı, Y., Kuyumcu, S., Başaran, B., & Mudun, A. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1242-3 · Cited by 14
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
Chu, Y., Chen, C.-W. D., Lai, M., Lim, S., & Lin, W.-R. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i29.4499 · Cited by 13
Dong, G., He, X., Chen, Y., Cao, H., Wang, J., Liu, X., Wang, S., Wan, S., & Xing, J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0442-x · Cited by 13
“Mutations in SDH complex have been initially observed in paraganglioma [29, 30], and subsequent studies have reported those mutations to be involved in T-cell leukemia and gastrointestinal stromal tumor [31, 32].”
BackgroundSatoh, N., Yokoyama, C., Itamura, N., Miyajima-Nakano, Y., & Hisatomi, H. (2014) · Oncology Letters · doi:10.3892/ol.2014.2699 · Cited by 13
“A number of mutations in human SDH genes are responsible for the development of PGLs, gastrointestinal stromal tumors and other types of cancer (5,18).”
Head and Neck Paraganglioma: Medical Assessment, Management, and Literature Update
Hayward, N. J., & Cousins, V. (2017) · Journal of Otorhinolaryngology Hearing and Balance Medicine · doi:10.3390/ohbm1010004 · Cited by 13
“These tumours have very low malignant potential [36,37].”
BackgroundSingh, D., Shukla, J., Walia, R., Vatsa, R., Paul, N., Chhabra, A., Nahar, U., Singh, H., Kumar, R., Bhansali, A. K., et al. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001251 · Cited by 13
Contiguous bilateral head and neck paragangliomas in a carrier of the SDHB germline mutation
Collins, N., & Dietzek, A. M. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.06.084 · Cited by 12
Laiho, P., Hienonen, T., Mecklin, J.-P., Järvinen, H., Karhu, A., Launonen, V., & Aaltonen, L. A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.e73 · Cited by 12
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.